ALLOX raises $10.5M seed to scale AI drug discovery platform
ALLOX closes $10.5M seed financing to scale drug discovery platform
AI Overview
ALLOX raised a $10.5M seed round led by Asabys through its Sabadell Asabys II fund.
Why it matters
ALLOX's seed round shows how AI plus high-throughput genetics is being applied to hard-to-drug targets like protein-protein interactions, with named investors and a new board chair.